These are press releases that are related to our Investor efforts. Releases are listed in chronological order and are archived by year. Sign-up to receive news as it is released using the email and RSS tools below.
-
Jun 25, 2020- Twenty-five percent absolute survival benefit at 5 years for patients receiving stereotactic ablative radiotherapy to all metastatic lesions